J2790 HCPCS code: Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)
J2790 is the HCPCS Level II code for injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.). In 2024 Medicare paid an average of $53.98 per service for J2790 across 147 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 3 per day on outpatient hospital claims. Medicare volume fell 37% from 2022 to 2024 (232 to 147 services). In 2024, about 147 clinicians billed Medicare for J2790 for 145 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1986-01-01 |
| Last action effective | 2014-01-01 |
Who bills J2790 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 147 |
| Medicare beneficiaries | 145 |
| States with claims | 1 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J2790, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 232 | 220 | $77.52 | $56.10 |
| 2023 | 182 | 173 | $75.62 | $52.88 |
| 2024 | 147 | 145 | $76.70 | $53.98 |
States with the most J2790 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Pennsylvania | 11 | $61.75 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 3 | Clinical: Data |
| practitioner claims | 1 | Clinical: Data |
Medicare policy articles for this code
- A57160: Billing and Coding: Immune Thrombocytopenia (ITP) Therapy (CGS Administrators, LLC (MAC - Part A, MAC - Part B))
Covered diagnoses (1 ICD-10-CM codes)
The diagnoses most often listed as covered in the policy articles above:
| ICD-10-CM | Diagnosis | Articles listing it |
|---|---|---|
| D69.3 | Immune thrombocytopenic purpura | 1 |
What changed for J2790
- 1986-01-01: J2790 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2790?
J2790 is the HCPCS Level II code for injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.). Short descriptor: "Rho d immune globulin inj".
How much does Medicare pay for J2790?
In 2024, the average Medicare payment was $53.98 per service (average allowed $76.70).
Does Medicare cover J2790?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
Which diagnoses support coverage for J2790?
Medicare policy articles that cite J2790 list 1 covered ICD-10-CM diagnosis codes across 1 article. The most cited include D69.3 (Immune thrombocytopenic purpura). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.
How many units of J2790 can be billed per day?
3 on outpatient hospital claims; 1 on practitioner claims (NCCI medically unlikely edits).
Related J27 codes
- J2700 — Injection, oxacillin sodium, up to 250 mg
- J2704 — Injection, propofol, 10 mg
- J2710 — Injection, neostigmine methylsulfate, up to 0.5 mg
- J2711 — Injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg
- J2720 — Injection, protamine sulfate, per 10 mg
- J2724 — Injection, protein c concentrate, intravenous, human, 10 iu
- J2725 — Injection, protirelin, per 250 mcg
- J2730 — Injection, pralidoxime chloride, up to 1 gm
- J2760 — Injection, phentolamine mesylate, up to 5 mg
- J2765 — Injection, metoclopramide hcl, up to 10 mg
- J2770 — Injection, quinupristin/dalfopristin, 500 mg (150/350)
- J2777 — Injection, faricimab-svoa, 0.1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2790
- Watch J2790 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2790
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.